Pages that link to "Item:Q2164665"
From MaRDI portal
The following pages link to Modeling the effect of gut microbiome on therapeutic efficacy of immune checkpoint inhibitors against cancer (Q2164665):
Displaying 5 items.
- A mechanistic systems pharmacology modeling platform to investigate the effect of PD-L1 expression heterogeneity and dynamics on the efficacy of PD-1 and PD-L1 blocking antibodies in cancer (Q2029579) (← links)
- Modeling tumour heterogeneity of PD-L1 expression in tumour progression and adaptive therapy (Q2684038) (← links)
- LRBmat: a novel gut microbial interaction and individual heterogeneity inference method for colorectal cancer (Q6136943) (← links)
- Mathematical modeling of tumor immune interactions: the role of anti-FGFR and anti-PD-1 in the combination therapy (Q6597999) (← links)
- Optimal control of tumor-lymphatic model with immuno-chemotherapy (Q6613321) (← links)
